1989
DOI: 10.1111/j.1439-0507.1989.tb02246.x
|View full text |Cite
|
Sign up to set email alerts
|

Alterations Produced by Sertaconazole on the Morphology and Ultrastructure of Candida albicans: Sertaconazol‐bedingte Veranderungen der Morphologie und Ultrastruktur von Candida albicans

Abstract: Summary: We studied the changes produced in Candida albicans yeast cells after treatment in vitro with sertaconazole, with light microscopy, transmission and scanning electron microscopy. Four different concentrations were evaluated (10‐‐6 M, 10‐‐5 M, 10‐‐4 M, 10‐‐3 M) and two times of action (12 and 17 h) for each concentration. This new antimycotic agent shows a considerable destructive effect in C. albicans cells. The alterations produced by sertaconazole were already manifested after 12 h at the concentra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
0
0
1

Year Published

1995
1995
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 18 publications
0
0
0
1
Order By: Relevance
“…Его MIC 50 и MIC 90 были равны 0,25 и 0,5 мкг/мл соответственно [12]. Cертаконазол оказывает прямое токсическое влияние на клеточную мембрану грибковых клеток всего через 10 мин после начала воздействия и обеспечивает гибель 90% грибковых клеток в течение 1 ч экспозиции сертаконазола в концентрации 0,008 г/мл [13]. Эффективность сертаконазола доказана как in vitro, так и in vivo.…”
Section: обсуждение и выводыunclassified
“…Его MIC 50 и MIC 90 были равны 0,25 и 0,5 мкг/мл соответственно [12]. Cертаконазол оказывает прямое токсическое влияние на клеточную мембрану грибковых клеток всего через 10 мин после начала воздействия и обеспечивает гибель 90% грибковых клеток в течение 1 ч экспозиции сертаконазола в концентрации 0,008 г/мл [13]. Эффективность сертаконазола доказана как in vitro, так и in vivo.…”
Section: обсуждение и выводыunclassified
“…The inhibition of ergosterol biosynthesis is determined by inhibiting the P450dependent Erg11p enzyme. In this way, the P450-dependent Erg11p enzyme is not able to catalyze the methylation of lanosterol to ergosterol, resulting in a damaged fungal cell membrane without the main bioregulator of fluidity, asymmetry and integrity [16][17][18][19][20]. Sertaconazole interacts with its biosynthetic route, depleting the levels of ergosterol and affecting the integrity of the cell producing lanosterol which damages the cellular architecture, fluidity and membrane permeability [19,20].…”
Section: Mechanisms Of Action Of Sertaconazolementioning
confidence: 99%
“…In this way, the P450-dependent Erg11p enzyme is not able to catalyze the methylation of lanosterol to ergosterol, resulting in a damaged fungal cell membrane without the main bioregulator of fluidity, asymmetry and integrity [16][17][18][19][20]. Sertaconazole interacts with its biosynthetic route, depleting the levels of ergosterol and affecting the integrity of the cell producing lanosterol which damages the cellular architecture, fluidity and membrane permeability [19,20]. Interaction between the azole molecule and the iron atom of the hemo group leads to the inactivation of the enzyme 14α-lanosterol demethylase.…”
Section: Mechanisms Of Action Of Sertaconazolementioning
confidence: 99%
See 2 more Smart Citations